@haleighweaver5's semaglutide claims, fact-checked

What does this video actually claim?

Haleigh promotes compounded semaglutide and tirzepatide as "affordable" weight loss options, calling them "the best decision ever." She's enthusiastic about the results but doesn't share specific data about her experience or timeline.

The video is essentially a testimonial with product promotion. She tags multiple weight loss hashtags and presents these medications as accessible alternatives to brand-name versions.

What's missing? Any mention of side effects, medical supervision, or the fact that these are prescription medications requiring doctor oversight.

Do compounded GLP-1 drugs actually work for weight loss?

Yes, but the evidence comes from studies of FDA-approved versions, not compounded formulations. The STEP 1 trial (Wilding et al., NEJM, 2021) showed 2.4mg semaglutide led to 14.9% body weight loss over 68 weeks.

For tirzepatide, the SURMOUNT-1 trial (Jastreboff et al., NEJM, 2022) found even better results. Participants lost 22.5% of body weight on the 15mg dose over 72 weeks.

Here's the catch: compounded versions aren't required to prove bioequivalence to brand-name drugs. You're assuming they work the same way, but there's no guarantee the dosing or absorption matches the studied formulations.

Are compounded versions actually "affordable"?

This depends entirely on your insurance and the compounding pharmacy's pricing. Haleigh presents affordability as fact, but costs vary wildly across providers and aren't standardized like FDA-approved medications.

Some compounded semaglutide runs $200-400 monthly, while others charge more. Brand-name Wegovy costs around $1,300 monthly without insurance, but many insurance plans cover it with prior authorization.

The FDA has warned about quality issues with compounded GLP-1 drugs. Some have contained incorrect dosing or impurities. You might save money upfront but face risks from unregulated manufacturing.

What did she get wrong about safety and supervision?

Haleigh completely skips the medical supervision aspect. These aren't supplements you order online. Both semaglutide and tirzepatide require prescription oversight and regular monitoring.

The STEP trials required medical supervision throughout treatment. Participants had regular check-ins for side effects, dose adjustments, and safety monitoring. Common side effects include nausea, vomiting, and diarrhea in 20-50% of users.

More concerning: rare but serious risks include pancreatitis, gallbladder problems, and potential thyroid tumors (based on animal studies). The enthusiasm is understandable, but presenting these as casual weight loss tools misses critical safety considerations.

What should you actually know about GLP-1 medications?

These drugs work by slowing stomach emptying and affecting appetite-regulating hormones. They're genuinely effective for weight loss, but they're not magic bullets or lifestyle replacements.

The clinical trials required lifestyle modifications alongside medication. Participants received counseling on diet and exercise. Weight regain often occurs when stopping treatment, as shown in the STEP 1 extension study.

If you're considering GLP-1 medications, work with a qualified healthcare provider who can assess your candidacy, monitor for side effects, and ensure proper dosing. Compounded versions might be an option, but understand you're trading regulatory oversight for potential cost savings.